Regal Partners Ltd purchased a new stake in shares of Anteris Technologies Global Corp (NASDAQ:AVR - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,293,861 shares of the company's stock, valued at approximately $7,220,000. Anteris Technologies Global makes up about 0.7% of Regal Partners Ltd's investment portfolio, making the stock its 28th largest position. Regal Partners Ltd owned 3.60% of Anteris Technologies Global at the end of the most recent quarter.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Nantahala Capital Management LLC bought a new position in Anteris Technologies Global during the fourth quarter valued at $9,300,000. ADAR1 Capital Management LLC bought a new position in shares of Anteris Technologies Global during the 4th quarter worth $5,876,000. Altium Capital Management LLC purchased a new stake in Anteris Technologies Global in the 4th quarter worth about $4,112,000. Affinity Asset Advisors LLC bought a new stake in Anteris Technologies Global in the 4th quarter valued at about $1,674,000. Finally, MASO CAPITAL PARTNERS Ltd purchased a new stake in Anteris Technologies Global during the fourth quarter valued at about $976,000.
Anteris Technologies Global Trading Down 5.2 %
NASDAQ AVR traded down $0.23 during trading on Monday, hitting $4.20. The company had a trading volume of 30,923 shares, compared to its average volume of 216,392. The stock has a fifty day simple moving average of $4.92. Anteris Technologies Global Corp has a one year low of $2.34 and a one year high of $8.79.
Analyst Upgrades and Downgrades
AVR has been the subject of a number of recent research reports. Cantor Fitzgerald started coverage on shares of Anteris Technologies Global in a research note on Tuesday, January 7th. They issued an "overweight" rating and a $9.00 price objective for the company. TD Cowen began coverage on Anteris Technologies Global in a research note on Tuesday, January 7th. They set a "buy" rating and a $15.00 price objective on the stock. Barclays initiated coverage on Anteris Technologies Global in a report on Tuesday, January 7th. They set an "overweight" rating and a $22.00 target price for the company. Finally, Lake Street Capital started coverage on shares of Anteris Technologies Global in a report on Wednesday, January 8th. They issued a "buy" rating and a $20.00 price target on the stock.
Get Our Latest Stock Analysis on Anteris Technologies Global
Anteris Technologies Global Company Profile
(
Free Report)
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Read More
Before you consider Anteris Technologies Global, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.
While Anteris Technologies Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
